Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients

MARIA ANGELES AGUIRRE ZAMORANOCARLOS PÉREZ SÁNCHEZ2026-01-292026-01-29202010.1016/j.autrev.2020.1024882-s2.0-85082135479https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31537ImmunologyImmunology and AllergyCirculating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patientsletter